These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7198475)

  • 21. [Clinical study of a new anthranilic acid derivative: flufenamic acid].
    Colombo B; Chériè Lignière G; Mantellini P
    Reumatismo; 1969; 21(3):114-21. PubMed ID: 4929605
    [No Abstract]   [Full Text] [Related]  

  • 22. [Contribution to the evaluation of anti-inflammatory agents in vitro].
    Mörsdorf K; Cornelissen G
    Med Pharmacol Exp Int J Exp Med; 1966; 15(4):399-403. PubMed ID: 6012770
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antirheumatics in a narrower sense].
    Gross D
    Ther Umsch; 1972 Aug; 29(8):502-4. PubMed ID: 4538298
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental observations on flufenamic, mefanamic and meclofenamic acids. II. Toxicology in animals.
    Kaump DH
    Ann Phys Med; 1966; Suppl():16-23. PubMed ID: 4979051
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antineuritic (vitamin B 1, vitamin B 12), anti-inflammatory (mefenamic acid) and central sedative (anti-epileptic) therapy in the treatment of major and minor facial algias. (Physiopathological considerations)].
    Perfetti CC
    Riv Neurobiol; 1966; 12(1):55-63. PubMed ID: 5959309
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of di-n-butylphthalate biotransformation in cattle by liquid chromatography/ion trap mass spectrometry/mass spectrometry.
    Coldham NG; Dave M; Sauer MJ
    J Mass Spectrom; 1998 Sep; 33(9):803-10. PubMed ID: 9768498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of the experimental antitumor agent acridine carboxamide in the mouse.
    Robertson IG; Palmer BD; Paxton JW; Bland TJ
    Drug Metab Dispos; 1993; 21(3):530-6. PubMed ID: 8100511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infrared studies of the polymorphic states of the fenamates.
    Gilpin RK; Zhou W
    J Pharm Biomed Anal; 2005 Mar; 37(3):509-15. PubMed ID: 15740911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships in a series of anti-inflammatory N-arylanthranilic acids.
    Kaltenbronn JS; Scherrer RA; Short FW; Jones EM; Beatty HR; Saka MM; Winder CV; Wax J; Williamson WR
    Arzneimittelforschung; 1983; 33(4A):621-7. PubMed ID: 6683967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo biotransformation of 17 alpha-methyltestosterone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry.
    Dumasia MC
    Rapid Commun Mass Spectrom; 2003; 17(4):320-9. PubMed ID: 12569442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Trial of a new analgesic: mefenamic acid].
    Figarella J; Menguy P; Cohen M
    Mars Med; 1968; 105(7):637-40. PubMed ID: 5697871
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
    Van Antwerpen P; Dufrasne F; Lequeux M; Boudjeltia KZ; Lessgyer I; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2007 Sep; 570(1-3):235-43. PubMed ID: 17610876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Flufenamic acid in the therapy of rheumatoid arthritis].
    Gigante D; Teodori S
    Clin Ter; 1968 Jul; 46(1):3-13. PubMed ID: 5703789
    [No Abstract]   [Full Text] [Related]  

  • 34. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
    Trushin N; Hecht SS
    Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synthesis and pharmacologic property of anthranilic acid-N-(aryl-substitutes)].
    Picciola G; Gaggi R; Caliari W
    Farmaco Sci; 1968 May; 23(5):502-11. PubMed ID: 5680389
    [No Abstract]   [Full Text] [Related]  

  • 36. Migraine. Mefenamic acid (ponstan) in the treatment of attacks.
    Hall DW
    J R Coll Gen Pract; 1968 Apr; 15(4):321-4. PubMed ID: 5653300
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of postoperative pain with mefenamic acid].
    Hackl J
    Med Welt; 1967 Nov; 46():2796-9. PubMed ID: 5606417
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.
    Holmes EL
    Ann Phys Med; 1966; Suppl():36-49. PubMed ID: 4895006
    [No Abstract]   [Full Text] [Related]  

  • 39. [Flufenamic acid: therapeutic activity and secondary effects].
    Schiavetti L
    Clin Ter; 1972 Feb; 60(4):359-65. PubMed ID: 4260117
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of acute and chronic adnexitis using flufenamic acid].
    Foix A; Creo C; Simone L; De Mayer RL
    Prensa Med Argent; 1969 Aug; 56(25):1244-7. PubMed ID: 5379733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.